Celiac Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Vitamins & Minerals, Gluten-free Diet), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Celiac Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Vitamins & Minerals, Gluten-free Diet), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030


Sewing Machine Market Growth & Trends

The global sewing machine market size is expected to reach USD 6.80 billion by 2030, registering a CAGR of 6.0% over the forecast period, according to a new report by Grand View Research, Inc. Expansion of the clothing industry, changing consumer demand as per fashion trends, and demand for the mass clothing production are driving the market. Moreover, increasing population and rising disposable income are contributing to the industry growth.

Further, a rise in the usage of automation in the sewing sector is anticipated to increase the need for newer machines. Several businesses operating in the sector are witnessing shifts in their value chain owing to the adoption of 3D printing and AI. Advantages such as production efficiency, reduced downtime, and lower operating costs are supporting the demand for digitalization in the market.

Manufacturers are attempting to maintain their brand image and increase customer loyalty by introducing revolutionary sewing machine designs tailored to individual customer requirements and researching consumer behavior trends. The market's leading companies provide unique designs crafted from diamonds, gold, platinum, and other high-value materials.

Sewing Machine Market Report Highlights
  • The electric segment dominated the market and contributed to the largest revenue share of more than 44.8% in 2024. Electric motors in the apparel business reduce labor requirements and help in bulk production.
  • The shoes segment is forecasted to witness the highest CAGR of over 8.0% from 2025 to 2030. Rapid expansion in the footwear industry is contributing to the growth rate of the segment.
  • The industrial application segment accounted for the largest revenue share of more than 60% in 2024. To satisfy the rising demand for clothes from the growing population, manufacturers are adopting electric and computerized sewing machines. Clothing manufacturers are interested to reduce complexity and save the time and energy required for production.
  • The commercial segment is forecasted to witness a CAGR of over 4.0% from 2025 to 2030. The segment majorly includes the altering and tailoring business. The sewing machines used for these applications have a feature of treads and table adjustable. The altering and tailoring business is growing, which, in turn, will drive the market.
  • Asia Pacific dominated the market and accounted for the largest revenue share of over 41.7% in 2024. The region is expected to witness the highest CAGR of over 6.0% from 2025 to 2030. Frequently changing styles of clothes and increasing disposable income of citizens are the driving factors in this region.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Celiac Disease Treatment Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Celiac Disease Treatment Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Celiac Disease Treatment Market: Treatment Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Celiac Disease Treatment Market: Treatment Movement Analysis, 2023 & 2030 (USD Million)
4.3. Vitamins and Minerals
4.3.1. Vitamins and Minerals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Gluten-free Diet
4.4.1. Gluten-free Diet Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Medical Therapies
4.5.1. Medical Therapies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.1. Infliximab
4.5.1.1.1. Infliximab Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.2. Larazotide Acetate
4.5.1.2.1. Larazotide Acetate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.3. Azathioprine
4.5.1.3.1. Azathioprine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.4. Budesonide
4.5.1.4.1. Budesonide Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.5. Others
4.5.1.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Celiac Disease Treatment Market: Route of Administration Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Celiac Disease Treatment Market: Route of Distribution Movement Analysis, 2023 & 2030 (USD Million)
5.3. Oral
5.3.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Parenteral
5.4.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Celiac Disease Treatment Market: Distribution Channel Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Celiac Disease Treatment Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospital
6.3.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Research Centers
6.4.1. Research Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Celiac Disease Treatment Market: Regional Estimates & Trend Analysis
7.1. Celiac Disease Treatment Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
7.2.1. North America Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Teva Pharmaceutical Industries Ltd.
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Amgen Inc.
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Amneal Pharmaceuticals LLC.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Glenmark Life Sciences Limited
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Takeda Pharmaceutical Company Limited.
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Hikma Pharmaceuticals PLC
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Viatris Inc.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Zydus Pharmaceuticals, Inc.
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Novartis AG
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. BioLineRx Ltd.
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings